Internal Medicine · Panorama City, CA
NPI
1225186141
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13652 Cantara St
Panorama City, CA, 91402
Phone (818) 375-2000
Groups this clinician bills Medicare through
Medicare paid, 2022
$1,466
26 services
Medicare patients, 2022
17
Average age 64
Drug cost, 2024
$310K
7,443 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Douglas S Weese prescribed most often to Medicare patients was Atorvastatin Calcium, with 971 prescriptions and refills. In total Douglas S Weese wrote 7,443 Medicare prescriptions that cost $310K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 971 | 3,170 | 332 | $12K |
| Lisinopril Generic | 448 | 1,461 | 156 | $5,859 |
| Metformin Hcl Generic | 346 | 1,130 | 120 | $4,087 |
| Amlodipine Besylate Generic | 332 | 1,019 | 109 | $4,578 |
| Atenolol Generic | 254 | 841 | 86 | $3,567 |
| Glipizide Generic | 243 | 793 | 86 | $3,292 |
| Losartan Potassium Generic | 243 | 805 | 86 | $3,683 |
| Terazosin Hcl Generic | 211 | 675 | 69 | $17K |
| Omeprazole Generic | 198 | 640 | 82 | $2,318 |
| Levothyroxine Sodium Generic | 170 | 545 | 50 | $3,161 |
| Simvastatin Generic | 156 | 511 | 53 | $1,809 |
| Finasteride Generic | 134 | 438 | 49 | $2,047 |
| Ibuprofen Generic | 126 | 133 | 49 | $1,424 |
| Tamsulosin Hcl Generic | 117 | 354 | 43 | $2,047 |
| Rosuvastatin Calcium Generic | 116 | 381 | 43 | $1,361 |
Brand drugs: 555 claims; generic drugs: 6,751 claims; opioid claims: 125.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Douglas S Weese were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.